EGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung cancer

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Lin, Xiaofeng ^a,f   Zhong, Shuangshuang ^a   Ye, Xiaofeng ^a,g   Liao, Yueling ^a   Yao, Feng ^b   Yang, Xiaohua ^b   Sun, Beibei ^b   Zhang, Jie ^b   Li, Qi ^a   Gao, Yong ^c   Wang, Yifan ^d   Liu, Jingyi ^d   Han, Baohui ^b   Chin, Y Baohui ^b,e   Zhou, Binhua P ^d   Deng, Jiong ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c TONGJI UNIVERSITY   (China)

^d UNIVERSITY OF KENTUCKY   (United States)

^e INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^f Biopeptek Inc   (United States)

^g NicheUSA LLC   (United States)

Author keywords

EGFR; GPRC5A; Lung cancer; Post translation modification; Tyrosine kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER A; PHENYLALANINE; PROTEIN TYROSINE KINASE; TYROSINE; UNCLASSIFIED DRUG; GPRC5A PROTEIN, HUMAN; PHOSPHOTYROSINE; PROTEIN BINDING;

AMINO ACID SUBSTITUTION; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; ENZYME INACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LUNG PARENCHYMA; NON SMALL CELL LUNG CANCER; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING; WILD TYPE; AMINO ACID SEQUENCE; CELL ADHESION; CHEMISTRY; HEK293 CELL LINE; LUNG TUMOR; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE; TUMOR INVASION; TUMOR SUPPRESSOR GENE;

MUS;

AMINO ACID SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION; CELL LINE, TUMOR; GENES, TUMOR SUPPRESSOR; HEK293 CELLS; HUMANS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN BINDING; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84935000709     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-233     Document Type: Article

References (29)

1. Cheng Y, Lotan R: Molecular cloning and characterization of a novel retinoic acid-inducible gene that encodes a putative G protein-coupled receptor. J Biol Chem 1, 273:35008-35015. 10.1074/jbc.273.52.35008
2. Tao Q, Fujimoto J, Men T, Ye X, Deng J, Lacroix L, Clifford JL, Mao L, Van Pelt CS, Lee JJ, Lotan D, Lotan R: Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene. J Natl Cancer Inst 1, 99:1668-1682. 10.1093/jnci/djm208
3. Takeuchi S, Mori N, Koike M, Slater J, Park S, Miller CW, Miyoshi I, Koeffler HP: Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12. Cancer Res 1996, 56:738-740.
4. Grepmeier U, Dietmaier W, Merk J, Wild PJ, Obermann EC, Pfeifer M, Hofstaedter F, Hartmann A, Woenckhaus M: Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers. Int J Oncol 2005, 27:481-488.
5. Fujimoto J, Kadara H, Garcia MM, Kabbout M, Behrens C, Liu DD, Lee JJ, Solis LM, Kim ES, Kalhor N, Moran C, Sharafkhaneh A, Lotan R, Wistuba II: G-protein coupled receptor family C, group 1, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer. J Thorac Oncol 2012, 7:1747-1754. 10.1097/JTO.0b013e31826bb1ff
6. Deng J, Fujimoto J, Ye XF, Men TY, Van Pelt CS, Chen YL, Lin XF, Kadara H, Tao Q, Lotan D, Lotan R: Knockout of the tumor suppressor gene Gprc5a in mice leads to NF-kappaB activation in airway epithelium and promotes lung inflammation and tumorigenesis. Cancer Prev Res (Phila) 1, 3:424-437. 10.1158/1940-6207.CAPR-10-0032
7. Wu Q, Ding W, Mirza A, Van Arsdale T, Wei I, Bishop WR, Basso A, McClanahan T, Luo L, Kirschmeier P, Gustafson E, Hernandez M, Liu S: Integrative genomics revealed RAI3 is a cell growth-promoting gene and a novel P53 transcriptional target. J Biol Chem 1, 280:12935-12943. 10.1074/jbc.M409901200
8. Hirano M, Zang L, Oka T, Ito Y, Shimada Y, Nishimura Y, Tanaka T: Novel reciprocal regulation of cAMP signaling and apoptosis by orphan G-protein-coupled receptor GPRC5A gene expression. Biochem Biophys Res Commun 1, 351:185-191. 10.1016/j.bbrc.2006.10.016
9. Nagahata T, Sato T, Tomura A, Onda M, Nishikawa K, Emi M: Identification of RAI3 as a therapeutic target for breast cancer. Endocr Relat Cancer 1, 12:65-73. 10.1677/erc.1.00890
10. Marchese A, Paing MM, Temple BR, Trejo J: G protein-coupled receptor sorting to endosomes and lysosomes. Annu Rev Pharmacol Toxicol 1, 48:601-629. 10.1146/annurev.pharmtox.48.113006.094646
11. Ulloa-Aguirre A, Conn PM: Targeting of G protein-coupled receptors to the plasma membrane in health and disease. Front Biosci (Landmark Ed) 2009, 14:973-994.
12. Premont RT, Gainetdinov RR: Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol 1, 69:511-534. 10.1146/annurev.physiol.69.022405.154731
13. Tobin AB, Butcher AJ, Kong KC: Location, location, location.site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling. Trends Pharmacol Sci 1, 29:413-420. 10.1016/j.tips.2008.05.006
14. Wang J, Guan E, Roderiquez G, Calvert V, Alvarez R, Norcross MA: Role of tyrosine phosphorylation in ligand-independent sequestration of CXCR4 in human primary monocytes-macrophages. J Biol Chem 1, 276:49236-49243. 10.1074/jbc.M108523200
15. Brambilla C, Spiro S: Highlights in lung cancer. Eur Respir J 1, 18:617-618. 10.1183/09031936.01.00238801
16. Hirsch FR, Varella-Garcia M, Bunn PA Jr, Di Maria MV, Veve R, Bremmes RM, Baron AE, Zeng C, Franklin WA: Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 1, 21:3798-3807. 10.1200/JCO.2003.11.069
17. Stephens P, Hunter C, Bignell G, Edkins S, Davies H, Teague J, Stevens C, O'Meara S, Smith R, Parker A, Barthorpe A, Blow M, Brackenbury L, Butler A, Clarke O, Cole J, Dicks E, Dike A, Drozd A, Edwards K, Forbes S, Foster R, Gray K, Greenman C, Halliday K, Hills K, Kosmidou V, Lugg R, Menzies A, Perry J, et al.: Lung cancer: intragenic ERBB2 kinase mutations in tumours. Nature 2004, 431:525-526.
18. Riese DJ 2nd, Gallo RM, Settleman J: Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis. Bioessays 1, 29:558-565. 10.1002/bies.20582
19. Sharma SV, Bell DW, Settleman J, Haber DA: Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 1, 7:169-181. 10.1038/nrc2088
20. Okamoto Y, Ninomiya H, Masaki T: Posttranslational modifications of endothelin receptor type B. Trends Cardiovasc Med 1, 8:327-329. 10.1016/S1050-1738(98)00027-9
21. Qanbar R, Bouvier M: Role of palmitoylation/depalmitoylation reactions in G-protein-coupled receptor function. Pharmacol Ther 1, 97:1-33. 10.1016/S0163-7258(02)00300-5
22. Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, Nardone J, Lee K, Reeves C, Li Y, Hu Y, Tan Z, Stokes M, Sullivan L, Mitchell J, Wetzel R, Macneill J, Ren JM, Yuan J, Bakalarski CE, Villen J, Kornhauser JM, Smith B, Li D, Zhou X, Gygi SP, Gu TL, Polakiewicz RD, Rush J, Comb MJ: Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 1, 131:1190-1203. 10.1016/j.cell.2007.11.025
23. Wolf-Yadlin A, Kumar N, Zhang Y, Hautaniemi S, Zaman M, Kim HD, Grantcharova V, Lauffenburger DA, White FM: Effects of HER2 overexpression on cell signaling networks governing proliferation and migration. Mol Syst Biol 2006, 2:54.
24. Kikuchi A, Kishida S, Yamamoto H: Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Exp Mol Med 1, 38:1-10. 10.1038/emm.2006.1
25. Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC: Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 1, 6:931-940. 10.1038/ncb1173
26. Kumar N, Zaman MH, Kim HD, Lauffenburger DA: A high-throughput migration assay reveals HER2-mediated cell migration arising from increased directional persistence. Biophys J 1, 91:L32-L34. 10.1529/biophysj.106.088898
27. Liu SL, Zhong SS, Ye DX, Chen WT, Zhang ZY, Deng J: Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma. J Oral Pathol Med 1, 42:761-768. 10.1111/jop.12077
28. Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM, Zhou BP: Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 1, 15:416-428. 10.1016/j.ccr.2009.03.016
29. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC: Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 1, 3:245-252. 10.1038/35060032